Synchronized cardiovascular support now ready for the market
Xenios AG concludes its first clinical study on i-cor Synchronized Cardiac Assist, documenting the safety and feasibility of the synchronized cardiovascular support system. During the “SynCor” trial, a multicentre study treated 47 patients in nine different German clinics using an innovative pulsatile, cardiac-synchronous circulatory support system. The aim of the ...
Relaunch of the Xenios Website – now harmonized with that of its parent, Fresenius Medical Care
The Xenios AG, pioneer in extracorporeal heart and lung support, has restructured its website. Xenios AG has been part of the Fresenius Medical Care Group since 2016 and the new design also serves to bring the company visually in line with the brand image of its parent. www.xenios-ag.com With this ...
View our latest brochure Heart and Lung Assist for Pediatric Patients
View our latest brochure Heart and Lung Assist for Pediatric Patients.
Shaping the future of multi organ support – Novalung and Fresenius Medical Care at the ISICEM Brussels 2019
Shaping the future of multi organ support – Novalung and Fresenius Medical Care at the ISICEM Brussels 2019.
Novalung at ESCIM Paris 2018 – Session and Workshop Report
Novalung at ESCIM Paris 2018 Session and Workshop Report
VV ECMO in severe ARDS: EOLIA trial results show benefit for patients
The results of the ECMO to rescue lung injury in severe ARDS (EOLIA) trial have long been awaited, since the first two trials in this field were already conducted decades ago and the results were controversial. The investigators around Prof. Alain Combes showed now in the largest international randomized multicentre setup so far, that ...
09. – 11. May
DAC 2019 – Jahreskongress der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin – Leipzig, Germany
28. September – 02. October
ERS Lives 2019
ERS Lives 2019 - European Respiratory Society International Congress 2019 - Madrid, Spain